Senate Bill 1091
2021-2022 Regular Session
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Co-Sponsorship Memo
Prime Sponsor
Senator Doug Mastriano
R Senate District 33
Co-Sponsors
Sen. Kristin Phillips-Hill
R Senate District 28
Sen. Judy Ward
R Senate District 30
Sen. Patrick Stefano
R Senate District 32
Sen. Mario Scavello
R Senate District 40
Bill Status & History
Last Action: Referred to Health & Human Services, Feb. 23, 2022
Senate
S
H
| 1424 | Referred to Health & Human Services, Feb. 23, 2022 |
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
There are no statute references for this bill.
Senate Bill 1091
2021-2022 Regular Session
Sponsors
MASTRIANO, PHILLIPS-HILL, J. WARD, STEFANO, SCAVELLO
Short Title
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Memo Subject
Increasing Access to COVID Early Treatment Drugs
Actions
| 1424 | Referred to HEALTH AND HUMAN SERVICES, Feb. 23, 2022 |
Generated 05/20/2025 02:00 AM